U.S. Pharma Stock News

Innovative Industrial Properties (IIPR) is back in focus after investors learned of a class action lawsuit alleging misrepresentation of leasing profitability, along with a new US$20 million secured term loan that changes its debt profile. See our latest analysis for Innovative Industrial Properties. Recent headlines around the class action filing and the new US$20 million secured term loan come after a period where the stock shows a 30 day share price return of 8.52% and a 1 year total...

Performance snapshot and why Sabra might be on your radar Sabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly 11% in the past 3 months. For income focused investors watching healthcare real estate, that move, combined with a market value of about US$5.1b and reported annual revenue of US$815.664m, may prompt a closer look at what is driving sentiment. See our latest analysis for Sabra Health Care REIT. At a share...

If you are wondering whether Wyndham Hotels & Resorts stock still offers value after recent swings, you are not alone. The share price closed at US$80.84, with a 5.3% decline over the last 7 days and a 1.6% decline over 30 days, while the stock shows a 7.4% return year to date, a 1.9% decline over 1 year, 26.8% over 3 years, and 20.8% over 5 years. Recent headlines around Wyndham have focused on its position in the hotel and resort industry and how investors are weighing the balance between...

Board appointment puts AI expertise in focus for Procore Technologies (PCOR) Procore Technologies (PCOR) has added Vishal Misra, a long-time Columbia University computer science professor and technology entrepreneur, to its Board of Directors, putting fresh attention on how AI expertise might intersect with the construction software company. See our latest analysis for Procore Technologies. Procore’s recent 1-day share price return of 4.84% and 90-day share price return of 16.41%, compared...

CACI International Inc. recently reported third-quarter fiscal 2026 results, with sales of US$2,351 million and net income of US$130.39 million, and updated full-year guidance to revenue of US$9,500 million–US$9,600 million and net income of US$481 million–US$496 million. The company’s higher year-on-year sales and earnings, alongside raised full-year guidance, underline management’s confidence in its operating performance and earnings profile. We’ll now examine how CACI’s raised full-year...

In April 2026, Digital Realty Trust raised its 2026 guidance, now expecting total revenue between US$6.65 billion and US$6.75 billion and net income per diluted share between US$2.65 and US$2.75, following strong first-quarter results with record annualized bookings and its largest lease to date. The updated outlook, underpinned by significant AI-related demand and a growing development pipeline, highlights how Digital Realty is leaning on long-term lease commitments and access to capital to...

In the first quarter of 2026, Waste Connections reported higher sales of US$2,370.63 million but lower net income of US$219.34 million year over year, while maintaining its regular US$0.35 quarterly dividend and continuing share repurchases under its existing buyback program. Management also signaled an “above-average” year for acquisitions, citing a robust pipeline including about US$100 million in annualized revenue from deals expected to close by early third quarter, alongside early gains...

Quantum computing is moving from theory to tangible products at the same time as investors are dealing with higher inflation, elevated bond yields and energy related uncertainty. In this setting, some prefer themes where long term research and intellectual property matter as much as near term growth. The Quantum Computing Stocks screener focuses on companies working on hardware, software and research around quantum algorithms and superconducting qubits. It can help you quickly narrow a...

Neogen (NEOG) came into focus after a recent move in its share price, with the stock last closing at $9.53. For investors, that price helps frame the discussion around value and expectations. See our latest analysis for Neogen. That recent move sits within a mixed picture, with a strong year to date share price return of 36.14% and a 1 year total shareholder return of 68.97% contrasting with a 3 year total shareholder return of 44.46% and a 5 year total shareholder return of 79.38%. This...

PROG Holdings earnings and guidance move into focus PROG Holdings (PRG) has put fresh attention on its stock after reporting first quarter results and lifting full year 2026 revenue and earnings guidance, a combination many investors watch closely. See our latest analysis for PROG Holdings. Investors have reacted quickly to the raised guidance and first quarter results, with the share price at US$36.19 and a 7 day share price return of 19.68% adding to a 23.22% year to date gain. The 1 year...

Cardinal Health (CAH) just delivered quarterly earnings that topped profit expectations, prompting management to lift full year adjusted EPS guidance, even as revenue shortfalls, pricing pressure and impairment charges kept investor attention on execution. See our latest analysis for Cardinal Health. At a share price of US$195.24, Cardinal Health has retreated with a 30 day share price return of 8.79% and a 90 day share price return of 10.44%, even as repeated earnings beats, raised guidance...

Wondering whether BXP at around US$59.37 is offering value or just value traps? This article breaks down what the current price might really mean for you. The stock has recently shown mixed returns, with a 2.3% gain over the last week and 14.7% over the last month, set against a year to date return of a 12.5% decline and a 1 year return of a 3.8% decline. Over the longer term, the picture is uneven, with a 37.9% gain across 3 years contrasted by a 29.0% decline over 5 years. This can leave...

Piedmont Realty Trust (PDM) has drawn fresh attention after its Q1 2026 earnings, where strong leasing momentum, high tenant retention, and record rental rates sat alongside a GAAP net loss and a suspended dividend. See our latest analysis for Piedmont Realty Trust. At a share price of $8.33, the stock’s recent 30 day share price return of 26.98% contrasts with a relatively flat 90 day move and a 1 year total shareholder return of 28.35%. This suggests momentum has picked up only in the very...

In April 2026, Target Hospitality Corp. completed a follow-on equity offering of 7,000,000 common shares, raising approximately US$98,000,000 at US$14 per share with a US$0.735 discount per share. This fresh equity capital, raised through a sizeable common stock issuance, has implications for existing shareholders, future funding flexibility, and the company’s long-term capital structure. Next, we’ll examine how this US$98,000,000 equity raise may reshape Target Hospitality’s investment...

Planet Labs PBC recently launched three additional Pelican satellites, including the first under a satellite services agreement with the Swedish Armed Forces, and separately announced plans to design a SWIR-only Tanager spacecraft with Carbon Mapper and Jet Propulsion Laboratory to enhance environmental monitoring capabilities. These moves highlight Planet’s push into higher-value defense and climate applications, pairing rapid sovereign satellite deployment with more specialized, AI-enabled...

Crypto and blockchain are back in focus as investors look for assets that can handle higher energy costs, sticky inflation risks, and shifting central bank plans. With AI-related demand supporting parts of global trade and payment systems under pressure from geopolitical tension, the broader digital infrastructure story is still evolving. The Top Cryptocurrency and Blockchain Stocks screener cuts through the noise by highlighting companies directly linked to this theme, without relying on...

Summit Therapeutics (SMMT) has drawn intense attention after its stock dropped sharply following updates that its key Phase III ivonescimab trial will continue without an early efficacy signal, alongside wider first quarter losses and a flagged going concern risk. See our latest analysis for Summit Therapeutics. The latest Q1 loss and going concern warning have triggered a sharp reset in sentiment, with a 1-day share price return of -24.91% and a 7-day share price return of -27.15%. This has...

Centerspace (CSR) heads into its Q1 2026 earnings report with analysts expecting a wider quarterly loss of $0.33 per share and slightly lower revenue compared with the same period a year earlier. See our latest analysis for Centerspace. The recent 30 day share price return of 14.16% and 90 day share price return of 6.54% suggest short term momentum is building. The 1 year total shareholder return of 17.83% points to steadier gains over time as investors weigh Q1 expectations and the new 5.17%...

Amer Sports (AS) is back in focus after management highlighted strong momentum at Arc’teryx and Salomon, with particular traction in women's products and footwear as well as solid demand across EMEA and North America. See our latest analysis for Amer Sports. The recent focus on Arc’teryx and Salomon comes as Amer Sports trades at US$35.25, with a 30 day share price return of 5.54% and a 1 year total shareholder return of 37.05%, hinting that momentum has picked up again after earlier...

In late April 2026, Duke Energy secured South Carolina Public Service Commission approval to combine Duke Energy Carolinas and Duke Energy Progress, while also receiving long-term operating license renewal for its H.B. Robinson Nuclear Plant through 2050 and canceling a legacy reimbursement agreement in Florida. Together, these decisions reinforce Duke Energy’s focus on simplifying its regulated utility structure, extending nuclear generation life, and aligning future grid investments with...

Xcel Energy stock snapshot after recent performance Xcel Energy (XEL) has drawn attention after a recent mix of short term and longer term returns, with the stock last closing at $82.58 and posting a 0.4% decline over the past day. See our latest analysis for Xcel Energy. That small one-day share price pullback comes after stronger momentum in recent months, with a 90-day share price return of 8.7% and a one-year total shareholder return of 20.2%, which hints at gradually improving sentiment...

Cohu (COHU) gave investors fresh data to work with after first quarter 2026 results, combining higher semiconductor test demand tied to AI and high performance computing with updated guidance and a larger opportunity pipeline. See our latest analysis for Cohu. Those stronger AI and high performance computing headlines have arrived alongside a sharp re-rating, with an 85.25% year to date share price return and a very large 1 year total shareholder return, even after a recent 3.72% 1 day...

IDACORP (IDA) reported first quarter 2026 earnings per share above consensus, supported by customer growth, larger industrial loads and tight cost control. The company reaffirmed full-year guidance and highlighted ongoing investments in gas plants and transmission. See our latest analysis for IDACORP. The latest earnings beat and reaffirmed guidance come after a solid run, with the share price at US$147.09 and a year-to-date share price return of 15.55%. The 1-year total shareholder return of...

Sherwin-Williams (SHW) just delivered Q1 2026 results that came in ahead of expectations, reaffirmed its full year outlook and highlighted its new zero-VOC Emerald Symmetry paint as a sustainability-focused product launch. See our latest analysis for Sherwin-Williams. The stock has softened in recent weeks, with a 7 day share price return of 5.39% and a 90 day share price return of an 11.58% decline. However, the 3 year total shareholder return is 41.41%, suggesting longer term holders are...